title: Treatment of short stature and delayed adolescence.
abstract: The treatment of growth failure in children with documented GH deficiency remains the only noncontroversial indication for GH therapy. There are increasing data suggesting that GH may be useful in treating some children with Turner's syndrome and with NVSS. Further studies, however, are necessary to evaluate the long-term efficacy and safety of GH therapy in these children. The treatment of non-GH deficient children whose heights are within two standard deviations of the mean height for age is clearly inappropriate and should be avoided, despite parental protests.
authors.forename: D M
authors.initials: DM
authors.lastname: Wilson
authors.forename: R G
authors.initials: RG
authors.lastname: Rosenfeld
mesh_terms: D000293:Adolescent; D001827:Body Height; D002648:Child; D005260:Female; D006130:Growth Disorders / Q000188:drug therapy* / Q000209:etiology; D013006:Growth Hormone / Q000172:deficiency / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010074:Oxandrolone / Q000627:therapeutic use; D011628:Puberty, Delayed / Q000188:drug therapy*; D013739:Testosterone / Q000627:therapeutic use; D014424:Turner Syndrome / Q000188:drug therapy
chemical_list: D013739:Testosterone; D010074:Oxandrolone; D013006:Growth Hormone